Korea FilingsFull brief — $39

JW PHARMACEUTICAL

JW중외제약(주) · KOSPI: 001060 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
JW중외제약(주)
Market / ticker
KOSPI · 001060
Industry
Pharmaceuticals and medicinal chemicals
Established
1945-08-08
Fiscal year ends
December
Website
www.jw-pharma.co.kr
DART corp code
00149947
Latest revenue
₩775.3B (FY2025)

Items worth checking

low
Filing on a change in the CEO line-up — filed 2025-12-01.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩748.5B₩719.4B₩775.3B
Operating income₩100.3B₩82.5B₩94.5B
Net income₩38.4B₩65.0B₩61.5B
Total assets₩645.0B₩604.6B₩605.3B
Total liabilities₩379.6B₩275.1B₩235.9B
Total equity₩265.4B₩329.5B₩369.4B
Share capital₩61.1B₩62.3B₩62.3B

Consolidated statements · FY2025 operating margin 12.2% · liabilities to equity 64% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 70 (current)한영회계법인Unqualified
Term 69 (prior)한영회계법인Unqualified
Term 68 (two years prior)한영회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-08-28Material management matterDART
2026-08-14Material management matterDART
2026-08-14Half-year report (2026.06)DART
2026-08-11Material management matterDART
2026-08-11Fair trade compliance program status (notice)DART
2026-08-11Preliminary operating results (fair disclosure)DART
2026-08-10종류주식의보통주식으로전환(안내공시)DART
2026-07-02Large shareholding (5%+) reportDART
2026-06-01Corporate governance reportDART
2026-05-15Quarterly report (2026.03)DART
2026-05-12Preliminary operating results (fair disclosure)DART
2026-04-30Material event reportDART
2026-04-30Trading suspension and releaseDART
2026-04-08Material management matterDART
2026-03-27Corporate value-up plan (voluntary)DART
2026-03-26Annual general meeting resultsDART
2026-03-26Independent director appointment / dismissal / resignationDART
2026-03-18Annual report (2025.12)DART
2026-03-13Audit report submittedDART
2026-03-11Amended: Proxy solicitation reference documentDART

Showing the 20 most recent of 37 filings. The full brief lists all of them.

Full brief on JW PHARMACEUTICAL — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.